Equol: Difference between revisions
CSV import |
CSV import |
||
| Line 35: | Line 35: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
== Equol == | |||
<gallery> | |||
File:Equol_structure.png|Equol structure | |||
</gallery> | |||
Revision as of 21:25, 23 February 2025
Equol is a metabolite of isoflavones, a type of phytoestrogen, that is produced by the action of gut microbiota. It is a non-steroidal estrogen that has been the subject of numerous studies due to its potential health benefits, particularly in relation to menopause, osteoporosis, and cardiovascular disease.
History
Equol was first isolated in 1982 from the urine of individuals who consumed soy products. It was named after the chemical structure of the compound, which is a 7-hydroxy-3-(4'-hydroxyphenyl)-chroman.
Production
Equol is produced in the gut by the action of certain types of bacteria, including Lactobacillus and Bifidobacterium. These bacteria convert dietary isoflavones, particularly daidzein, into equol.
Health Benefits
Numerous studies have suggested that equol may have a number of health benefits. These include:
- Menopause: Equol has been shown to alleviate some of the symptoms of menopause, including hot flashes and night sweats.
- Osteoporosis: Some research suggests that equol may help to prevent bone loss and reduce the risk of osteoporosis.
- Cardiovascular Disease: Equol may help to reduce the risk of cardiovascular disease by improving blood vessel function and reducing inflammation.
Safety and Side Effects
Equol is generally considered safe, with few reported side effects. However, as with any supplement, it should be used under the supervision of a healthcare provider.
